On March 9, at the press conference of the third session of the 14th National People's Congress, Lei Haichao, director of the National Health Commission, said that since the launch of the "Weight Management Year" last year, we should continue to carry out weight management.
Weight loss has become a hot topic today, and in the pharmaceutical industry, the most famous GLP-1 product in 2024 is being discussed due to its indications for weight loss.
In 2024, both semaglutide and tilpotide were approved for weight loss indications. According to Novo Nordisk's 2024 annual report, GLP-1 is Novo Nordisk's largest "money printer", with a total sales revenue of 29.28 billion US dollars for semaglutide, just one line away from the "king of drugs" K drug. And Tilpotide has been approved as the first and only prescription drug for the treatment of adult patients with moderate to severe obstructive sleep apnea (OSA) and obesity.
GLP-1 drugs have become an absolute hot topic, with a temptation of over 20 billion US dollars. Not only are foreign companies envious, but there are also dozens of domestic companies that have laid out GLP-1. The high sales of GLP-1 have given rise to a huge market for peptide active pharmaceutical ingredients.
According to a research report by CITIC Medicine, over 65% of the raw materials for peptide drugs worldwide are sourced externally.
In order to capture the market, peptide raw material manufacturers have not only rolled up prices, but also rolled up quality, production capacity, supporting services, and other aspects! Compared with small molecule components, the production of peptide raw materials is more difficult and there are higher technical barriers. For example, GLP-1 peptide raw materials typically contain forty to fifty amino acids. In chemical synthesis, every step must be error free. Once there is an amino acid connection error, the entire batch of drugs becomes waste.
On the one hand, this has achieved the variability of peptides, and on the other hand, it has also posed more challenges for raw material pharmaceutical companies. A reliable peptide drug raw material provider is very important!
A reliable one-stop service enterprise to serve you
Zhangzhou Weiming Boxin Biopharmaceutical Co., Ltd established in 2011, it is one of the first large-scale production enterprises in China specializing in the research and development, production, and technology transfer of peptide raw materials, cosmetic peptides, catalog peptides, and customer peptides. The company is located in Zhangzhou Development Zone, with a 100 acre peptide production base and a cGMP factory strictly established in accordance with international standards. It is equipped with a large number of the world's most advanced peptide synthesis and quality analysis instruments. Since its establishment, the company has utilized a high-throughput peptide synthesis platform with independent intellectual property rights,
Continuously providing high-quality, affordable, and high-tech peptides to pharmaceutical companies, biotechnology companies, universities, and research institutions both domestically and internationally.
Peptide API
Zhangzhou Weiming Boxin Biopharmaceutical has developed from a laboratory scale using GLP-1 raw materials, and now has an annual API production capacity of 50 kilograms.
CustomePeptide
Peptides have customer peptides due to their long chain structure and customizability, and can be selected in terms of type and modified structure. Weiming Boxin can provide synthesis and customization of over 1000 catalog peptides. To continuously meet the needs of our customers, the company will continue to follow up on the latest, cutting-edge, and hottest research directions, and provide the products you need with the highest quality standards.
CosmeticPeptide
In recent years, peptides, as an important "golden ingredient" in the cosmetics industry, have gained widespread attention in the market due to their unique biological activity and high efficiency. At present, there are various peptide ingredients on the market that have moisturizing, antioxidant, whitening, spot removing, anti wrinkle, and firming effects. These ingredients have higher compatibility and wider applicability, providing more possibilities for the innovation of cosmetics.Unnamed Boxin provides the following cosmetic peptide varieties：
TechnologyTransfer
Weiming Boxin provides customized services for enterprises with a top-notch research team, advanced equipment, and a mature industrialization team.
Note: If a product is within the patent protection period, it can only be used for research and development and cannot be used for commercial purposes
contact information
Tel：187-5054-6777【Rocky】
Email：SINOPEPT@GMAIL.COM
QQ：1580806664
Website： WWW.PEPTIDEE.COM
